Pharmazz, Inc.
Clinical trials sponsored by Pharmazz, Inc., explained in plain language.
-
Could a shock drug help ARDS patients breathe easier?
Disease control Not yet recruitingThis study tests whether centhaquine, a drug already approved for shock, can help people with moderate to severe acute respiratory distress syndrome (ARDS), a life-threatening lung condition. About 80 adults in the ICU will receive either centhaquine or a placebo alongside standa…
Phase: PHASE2 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New shock drug could save lives in critical care
Disease control Not yet recruitingThis study tests a new medicine called centhaquine for people in hypovolemic shock, a life-threatening condition where the body loses too much blood or fluid. About 430 adults will receive either centhaquine or a placebo alongside standard care. The main goal is to see if the dru…
Phase: PHASE3 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC